Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AGX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 5,716 | $579.64 | $3.3M Sale | Form 4 ↗ |
| Jun 22, 2026 | William F. Griffin Jr. Director | AGX Argan, Inc. | Sale | 20,000 | $760.43 | $15.2M Sale | Form 4 ↗ |
| Jun 18, 2026 | William F. Griffin Jr. Director | AGX Argan, Inc. | Sale | 30,000 | $725.85 | $21.8M Sale | Form 4 ↗ |
| Jun 17, 2026 | Joshua Scott Baugher Chief Financial Officer | AGX Argan, Inc. | Sale | 305 | $734.00 | $223.9K Sale | Form 4 ↗ |
| Jun 17, 2026 | Joshua Scott Baugher Chief Financial Officer | AGX Argan, Inc. | Sale | 455 | $732.83 | $333.4K Sale | Form 4 ↗ |
| Jun 17, 2026 | Karen Sweeney Director | AGX Argan, Inc. | Sale | 300 | $705.00 | $211.5K Sale | Form 4 ↗ |
| Jun 17, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 2,000 | $699.00 | $1.4M Sale | Form 4 ↗ |
| Jun 16, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 4,728 | $708.65 | $3.4M Sale | Form 4 ↗ |
| Jun 16, 2026 | David Hibbert Watson PRESIDENT AND CEO, Director | AGX Argan, Inc. | Sale | 1,880 | $707.35 | $1.3M Sale | Form 4 ↗ |
| Jun 15, 2026 | David Hibbert Watson PRESIDENT AND CEO, Director | AGX Argan, Inc. | Sale | 9,993 | $651.22 | $6.5M Sale | Form 4 ↗ |
| Jun 15, 2026 | Cynthia Flanders Director | AGX Argan, Inc. | Sale | 2,596 | $666.31 | $1.7M Sale | Form 4 ↗ |
| Jun 12, 2026 | William F. Griffin Jr. Director | AGX Argan, Inc. | Sale | 50,000 | $643.46 | $32.2M Sale | Form 4 ↗ |
| Apr 29, 2026 | Alexander Lisa Larroque Director | AGX Argan, Inc. | Sale | 350 | $630.58 | $220.7K Sale | Form 4 ↗ |
| Apr 29, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 3,000 | $628.36 | $1.9M Sale | Form 4 ↗ |
| Apr 28, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 400 | $618.61 | $247.4K Sale | Form 4 ↗ |
| Apr 28, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 400 | $621.14 | $248.5K Sale | Form 4 ↗ |
| Apr 28, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 5,000 | $617.41 | $3.1M Sale | Form 4 ↗ |
| Apr 27, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 2,698 | $664.84 | $1.8M Sale | Form 4 ↗ |
| Apr 21, 2026 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 11,068 | $621.61 | $6.9M Sale | Form 4 ↗ |
| Apr 21, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 3,636 | $615.40 | $2.2M Sale | Form 4 ↗ |
| Apr 20, 2026 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 2,500 | $610.00 | $1.5M Sale | Form 4 ↗ |
| Apr 17, 2026 | David Hibbert Watson PRESIDENT AND CEO, Director | AGX Argan, Inc. | Sale | 19,310 | $602.11 | $11.6M Sale | Form 4 ↗ |
| Apr 16, 2026 | Joshua Scott Baugher Chief Financial Officer | AGX Argan, Inc. | Sale | 600 | $605.60 | $363.4K Sale | Form 4 ↗ |
| Apr 13, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 8,444 | $598.49 | $5.1M Sale | Form 4 ↗ |
| Apr 2, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 2,581 | $552.73 | $1.4M Sale | Form 4 ↗ |
| Mar 31, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 4,556 | $539.85 | $2.5M Sale | Form 4 ↗ |
| Jan 27, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 5,000 | $360.78 | $1.8M Sale | Form 4 ↗ |
| Jan 21, 2026 | Cynthia Flanders Director | AGX Argan, Inc. | Sale | 19,000 | $386.70 | $7.3M Sale | Form 4 ↗ |
| Jan 20, 2026 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 2,700 | $380.60 | $1.0M Sale | Form 4 ↗ |
| Jan 16, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 11,044 | $379.15 | $4.2M Sale | Form 4 ↗ |
| Jan 13, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 4,212 | $320.53 | $1.4M Sale | Form 4 ↗ |
| Jan 12, 2026 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 2,164 | $318.28 | $688.8K Sale | Form 4 ↗ |
| Jan 8, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 6,595 | $313.71 | $2.1M Sale | Form 4 ↗ |
| Jan 7, 2026 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 4,000 | $328.34 | $1.3M Sale | Form 4 ↗ |
| Dec 23, 2025 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 100 | $337.93 | $33.8K Sale | Form 4 ↗ |
| Dec 23, 2025 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 100 | $337.01 | $33.7K Sale | Form 4 ↗ |
| Dec 10, 2025 | James W. Quinn Director | AGX Argan, Inc. | Sale | 1,000 | $328.04 | $328.0K Sale | Form 4 ↗ |
| Oct 20, 2025 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 6,493 | $294.39 | $1.9M Sale | Form 4 ↗ |
| Oct 17, 2025 | Peter W. Getsinger Director | AGX Argan, Inc. | Sale | 2,000 | $292.00 | $584.0K Sale | Form 4 ↗ |
| Oct 15, 2025 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 10,000 | $309.37 | $3.1M Sale | Form 4 ↗ |
| Oct 13, 2025 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 10,000 | $292.09 | $2.9M Sale | Form 4 ↗ |
| Oct 9, 2025 | David Hibbert Watson PRESIDENT AND CEO, Director | AGX Argan, Inc. | Sale | 559 | $272.27 | $152.2K Sale | Form 4 ↗ |
| Oct 9, 2025 | David Hibbert Watson PRESIDENT AND CEO, Director | AGX Argan, Inc. | Sale | 4,441 | $277.01 | $1.2M Sale | Form 4 ↗ |
| Oct 8, 2025 | Cynthia Flanders Director | AGX Argan, Inc. | Sale | 15,000 | $271.96 | $4.1M Sale | Form 4 ↗ |
| Oct 1, 2025 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 5,000 | $275.00 | $1.4M Sale | Form 4 ↗ |
| Oct 1, 2025 | William F. Leimkuhler Director | AGX Argan, Inc. | Sale | 11,802 | $274.73 | $3.2M Sale | Form 4 ↗ |
| Sep 30, 2025 | James W. Quinn Director | AGX Argan, Inc. | Sale | 13,444 | $269.12 | $3.6M Sale | Form 4 ↗ |
| Sep 29, 2025 | John Ronald Jeffrey Jr. Director | AGX Argan, Inc. | Sale | 4,698 | $268.60 | $1.3M Sale | Form 4 ↗ |
| Sep 24, 2025 | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | AGX Argan, Inc. | Sale | 5,000 | $267.00 | $1.3M Sale | Form 4 ↗ |
| Sep 22, 2025 | James W. Quinn Director | AGX Argan, Inc. | Sale | 4,660 | $259.35 | $1.2M Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances